McKesson hosts summit for leaders from health plans and labs

July 13, 2010

NEWTON, Mass., July 13, 2010 — McKesson recently held its first in a series of advanced diagnostics summits for health insurance plans and clinical laboratories to share ideas on how to ensure the most appropriate use of new advanced diagnostics. The event took place in May at Harvard Medical School in Boston, bringing together senior executives from Massachusetts market organizations to discuss how to optimize individual patients’ preventive and therapeutic care while reducing overall healthcare costs. McKesson will sponsor future summits in California, New York, Pennsylvania and other major healthcare markets.

Advanced diagnostics, such as molecular and genetic testing, offer great promise for improved care. But health plans and labs alike are challenged with ensuring appropriate utilization and reimbursement without clear answers to questions such as: Which tests should be covered? How should they be coded? How can physicians access the information they need for appropriate ordering? With a new molecular test being introduced every three to five days and the market for these tests growing at more than 20 percent annually, issues around test use, coding, reimbursements and authorization are compounding. And, because lab tests affect 70 percent of healthcare decisions, the potential impact of advanced diagnostics on the total cost of care is significant.

Summit participants gained a deeper understanding of each others’ environments while agreeing the current situation is not sustainable. Areas of consensus included a call for coding standards similar to NDC and NCPDP for pharmacy, access to transparent coverage information for clinicians and clinical labs and standardized test catalogues across constituents.

Sponsored Recommendations

The Healthcare Provider's Guide to Accelerating Clinician Onboarding

Improve clinician satisfaction and productivity to enhance patient care

ASK THE EXPERT: ServiceNow’s Erin Smithouser on what C-suite healthcare executives need to know about artificial intelligence

Generative artificial intelligence, also known as GenAI, learns from vast amounts of existing data and large language models to help healthcare organizations improve hospital ...

TEST: Ask the Expert: Is Your Patients' Understanding Putting You at Risk?

Effective health literacy in healthcare is essential for ensuring informed consent, reducing medical malpractice risks, and enhancing patient-provider communication. Unfortunately...

From Strategy to Action: The Power of Enterprise Value-Based Care

Ever wonder why your meticulously planned value-based care model hasn't moved beyond the concept stage? You're not alone! Transition from theory to practice with enterprise value...